Translational Development Acquisition (TDAC) Long-Term Investments (2024 - 2026)

Translational Development Acquisition's Long-Term Investments history runs 3 years deep, the most recent figure standing at $183.3 million for Q1 2026.

• Quarterly Long-Term Investments rose 4.02% year-over-year to $183.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.3 million (up 4.02% YoY) and the FY2025 annual result came in at $181.7 million, up 4.19% from the prior year.
• Long-Term Investments was $183.3 million for Q1 2026 at Translational Development Acquisition, up from $181.7 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $183.3 million in Q1 2026 and bottomed at $174.4 million in Q4 2024.
• A 3-year average of $178.9 million and a median of $179.0 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments rose 4.19% — and 2026, when it grew 4.02%.
• Translational Development Acquisition's Long-Term Investments stood at $174.4 million in 2024, then climbed by 4.19% to $181.7 million in 2025, then rose by 0.89% to $183.3 million in 2026.
• Business Quant data shows TDAC's Long-Term Investments at $183.3 million in Q1 2026, $181.7 million in Q4 2025, and $179.9 million in Q3 2025.